Clinical Pharmacology of Serotonin Selective Reuptake Inhibitors
Author: Sheldon Preskorn
Publisher:
Published: 1996
Total Pages: 255
ISBN-13: 9781884735097
DOWNLOAD EBOOK →Author: Sheldon Preskorn
Publisher:
Published: 1996
Total Pages: 255
ISBN-13: 9781884735097
DOWNLOAD EBOOK →Author: Sheldon Preskorn
Publisher: Professional Communications, Incorporated
Published: 1996
Total Pages: 0
ISBN-13: 9781884735080
DOWNLOAD EBOOK →Provides a summary of the clinically relevant pharmacology of five different SSRIs in a manner that is user-friendly. The goal of this book is to facilitate the optimum use of this important class of antidepressants.
Author: Renato D. Alarcón
Publisher: Springer Science & Business Media
Published: 2004-02-19
Total Pages: 644
ISBN-13: 9783540430544
DOWNLOAD EBOOK →With contribution by numerous experts
Author:
Publisher: ScholarlyEditions
Published: 2012-01-09
Total Pages: 45
ISBN-13: 1464942951
DOWNLOAD EBOOK →Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Selective Serotonin Reuptake Inhibitors in a concise format. The editors have built Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Selective Serotonin Reuptake Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitors: Advances in Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author:
Publisher: ScholarlyEditions
Published: 2012-12-26
Total Pages: 91
ISBN-13: 1481607758
DOWNLOAD EBOOK →Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Selective Serotonin Reuptake Inhibitors in a concise format. The editors have built Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Selective Serotonin Reuptake Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Selective Serotonin Reuptake Inhibitors—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Author: Graziano Pinna
Publisher:
Published: 2015-04-01
Total Pages: 412
ISBN-13: 9781634820769
DOWNLOAD EBOOK →Fluoxetine, best known by the trade name Prozac®, unlike other psychotropic drugs whose effects were serendipitously stumbled upon, was the first developed for a precise mechanism of action, that is, the ability to selectively inhibit serotonin reuptake, based upon the theory that increasing the availability of serotonin would treat major depression. Once approved by the FDA in 1987, fluoxetine quickly became the most prescribed psychotropic drug worldwide and its success in improving mood disorders has triggered the development of a large number of congener molecules, commonly known as SSRIs after their purported mechanism of action. However, a quarter of a century after its development, the idea that fluoxetine asserts its positive behavioral effect through inhibition of serotonergic reuptake is not firmly established. This book reviews several preclinical and clinical reports suggesting that the pharmacological effects of fluoxetine may be mediated by means other than the regulation of serotonin, including the regulation of gene expression, modifying epigenetic mechanisms as well as modifying microRNAs. One of the most prominent mechanisms for the therapeutic relevance of fluoxetine relates to influencing neuroplasticity by enhancing neurotropic factors, including BDNF signaling and altering adult neurogenesis. The ability of fluoxetine to rapidly increase neurosteroid levels accounts for the fast anxiolytic effects of this drug. Fluoxetine action at sigma-1 receptor or modulating glutamatergic neurotransmission as well as the combination of fluoxetine with other psychotropic drugs is discussed in relation to its therapeutic effects. While fluoxetine was primarily prescribed as an antidepressant, this drug currently represents a treatment of choice for a broad spectrum of psychiatric disorders, including post-traumatic stress disorder and a range of anxiety disorders. This drug even possesses analgesic actions and is a valuable therapy for stroke. This book also highlights emerging evidence on the gender-specific effects of fluoxetine, its potential adverse features, including its addiction liability in combination with psychostimulants, and the impact of perinatal fluoxetine exposure.
Author: Domenic A. Ciraulo
Publisher: Springer Science & Business Media
Published: 2010-12-28
Total Pages: 432
ISBN-13: 1603274359
DOWNLOAD EBOOK →Comprehensive and state of the art, the second edition of Pharmacotherapy of Depression offers major revisions of every chapter and the addition of new chapters by expert contributors. The first chapter reviews the neurobiology of depression, which lays the groundwork for understanding the mechanisms of action of antidepressants. In the next chapter, a review of the general principles guiding the diagnosis and medication treatment of unipolar depression is provided. The clinical pharmacology of antidepressants is reviewed in some detail, supplemented by tables that provide information on dosing, indications, and metabolism. Augmentation strategies are reviewed, including the use of non-traditional agents. The chapters that follow next address the use of antidepressants in special populations, such as the elderly and depressed individuals with psychosis, bipolar disorder, substance abuse, and post traumatic stress disorder. The complex issues involving the diagnosis and treatment of depression during pregnancy is thoroughly reviewed in Chapter 8 and provides a synthesis of the scientific literature in the area, one that is noted for contradictory and controversial findings, as well as guidelines for prescribing. The next chapter then provides an overview of the treatment of depression in the pediatric population, highlighting clinical concerns such as suicide risk. The book concludes with two chapters at the interface of medicine and psychiatry in the treatment of mood disorders: managing depression in primary care settings and depression associated with medical illnesses. The outstanding clinician-scientists who have contributed to this volume are all leaders in their fields and represent a broad spectrum of renowned institutions. A timely contribution to the literature, The Pharmacotherapy of Depression, Second Edition, offers busy clinicians from many disciplines a strong scientific foundation that seamlessly transitions into practical recommendations for clinical practice. The result is another gold-standard guide to the safe and effective use of the latest antidepressant medications.
Author: S. Clare Stanford
Publisher: Landes Bioscience
Published: 1999
Total Pages: 248
ISBN-13:
DOWNLOAD EBOOK →Details advantages and disadvantages of SSRIs. Starts with a personal memoir of the discovery of the first SSRI, then looks at SSRIs from the clinical point of view. Later chapters concentrate on preclinical material. A final chapter makes pharmacological and clinical comparisons between the tricycl
Author: Philip G. Janicak
Publisher: Lippincott Williams & Wilkins
Published: 2011-12-26
Total Pages: 712
ISBN-13: 1451178778
DOWNLOAD EBOOK →Fully updated for its Fifth Edition, Principles and Practice of Psychopharmacotherapy summarizes the latest data on hundreds of drug and device-based therapies and offers practical, evidence-based guidelines and treatment strategies for virtually every psychiatric disorder. Highlights of this edition include expanded coverage of pharmacogenomics, updates on treatments for elderly patients, and discussion of mechanisms of action for drugs used in sleep disorders, especially narcolepsy.
Author: J. P. Feighner
Publisher: Wiley
Published: 1996-06-19
Total Pages: 0
ISBN-13: 9780471956006
DOWNLOAD EBOOK →Interest in Selective Serotonin Re-Uptake Inhibitors has grown considerably in recent years, particularly as their therapeutic profile is expanding to the treatment of other types of psychiatric disorder besides depression. It is therefore timely that the authors of Selective Serotonin Re-Uptake Inhibitors should now provide a second edition. Reorganised and updated to include additional chapters which greatly extend the scope of the book, this edition gives an excellent review of the biochemical, pharmacological and clinical aspects of this important group of drugs. Written by an array of outstanding, authoritative, international scientists and clinicians this invaluable reference provides a wealth of knowledge and an extensive source of up-to-date references on a subject that is important to every clinician involved in treating psychiatric patients as well as those carrying out research in this field.